Compound Summary
Compound Name: | 			parthenolide | 
Compound CID: | 			7251185 | 
Synonyms: | 			parthenolide 20554-84-1 (-)-Parthenolide MFCD00134592 CHEBI:7939 More... | 
Iupac Name: | 			(1S,2R,4R,7E,11S)-4,8-dimethyl-12-methylidene-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one | 
InChI: | 					InChI=1S/C15H20O3/c1-9-5-4-8-15(3)13(18-15)12-11(7-6-9)10(2)14(16)17-12/h5,11-13H,2,4,6-8H2,1,3H3/b9-5+/t11-,12-,13+,15+/m0/s1 | 
InChIKey: | 				KTEXNACQROZXEV-PVLRGYAZSA-N | 
Canonical Smiles: | 		CC1=CCCC2(C(O2)C3C(CC1)C(=C)C(=O)O3)C | 
Isomeric Smiles: | 			C/C/1=C\CC[C@@]2([C@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C | 
Molecular Weight: | 		248.32 | 
Molecular Formula: | 			C15H20O3 | 
Molecular Weight: | 		248.32 | 
Molecular Formula: | 			C15H20O3 | 
Hydrogen Bond Donor Count: | 			0 | 
Hydrogen Bond Acceptor Count: | 			3 | 
Rotatable Bond Count: | 			0 | 
Heavy Atom Count: | 					18 | 
Complexity: | 				437 | 
| parthenolide | parthenolide | 
|---|---|
parthenolide | 			
20554-84-1 | 
(-)-Parthenolide | 			
MFCD00134592 | 
CHEBI:7939 | 			
4,5-alpha-Epoxy-6-beta-hydroxygermacra-1(10),11(13)-dien-12-oic acid gamma-lactone | 
(1aR,4E,7aS,10aS,10bR)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno9,10cyclodeca1,2-bfuran-9(1aH)-one | 			
29552-41-8 | 
partenolide | 			
Parthenolide, Tanacetum parthenium | 
Oxireno9,10cyclodeca1,2-bfuran-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)- | 			
Prestwick2_000550 | 
Prestwick3_000550 | 			
Epitope ID:115014 | 
SCHEMBL8220 | 			
BSPBio_000599 | 
BSPBio_001308 | 			
MLS002153872 | 
BPBio1_000659 | 			
CHEMBL465158 | 
parthenolide-(alternate-stereo) | 			
SCHEMBL13367522 | 
BCBcMAP01_000041 | 			
Parthenolide, >=98% (HPLC) | 
HMS1361B10 | 			
HMS1569N21 | 
HMS1791B10 | 			
HMS1989B10 | 
HMS2096N21 | 			
HMS3402B10 | 
HMS3713N21 | 			
BCP10404 | 
EX-A5460 | 			
HY-N0141 | 
ZINC4492886 | 			
AKOS016010226 | 
CCG-208244 | 			
CS-1919 | 
IDI1_033778 | 			
NCGC00163415-01 | 
NCGC00163415-04 | 			
AS-17479 | 
SMR001233226 | 			
AB0019832 | 
AB00513860 | 			
V0355 | 
552P418 | 			
Q-100253 | 
(-)-Parthenolide; NSC-157035; NSC 157035; NSC157035 | 			
Parthenolide, United States Pharmacopeia (USP) Reference Standard | 
(3aS,10R,11R,11aS,6E)-3-Methylene-6,10-dimethyl-10,11-epoxy-1-oxa-2,3,3a,4,5,8,9,10,11,11a-decahydro-1H-cyclopentacyclodecene-2-one | 			
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -11.000000000000000 | NS | N2 | 24134630 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | -11.000000000000000 | 1 | 1 |